Literature DB >> 2380367

Selective medium for Pasteurella multocida and its use to detect oropharyngeal carriage in pig breeders.

J L Avril1, P Y Donnio, P Pouedras.   

Abstract

A selective culture medium for isolation of Pasteurella multocida was prepared by incorporating 2 mg of amikacin per liter, 4 mg of vancomycin per liter, and 4 mg of amphotericin B per liter into Mueller-Hinton blood agar. Use of this medium revealed the presence of P. multocida in the oropharynges of 19 of the 49 pig breeders who were examined.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2380367      PMCID： PMC267948          DOI： 10.1128/jcm.28.6.1438-1440.1990

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Identification of type A strains of P multocida using staphylococcal hyaluronidase.

Authors:  G R Carter; S W Rundell
Journal:  Vet Rec       Date:  1975-04-12       Impact factor: 2.695

2.  Studies on Pasteurella septica. III. Strains from human beings.

Authors:  J E SMITH
Journal:  J Comp Pathol       Date:  1959-04       Impact factor: 1.311

3.  Infections in man due to Pasteurella multocide.

Authors:  F L Jones; C E Smull
Journal:  Pa Med       Date:  1973-04

4.  Identification of type D strains of Pasteurella multocida with acriflavine.

Authors:  G R Carter; P Subronto
Journal:  Am J Vet Res       Date:  1973-02       Impact factor: 1.156

5.  Selective media for Pasteurella multocida and Bordetella bronchiseptica.

Authors:  L E Garlinghouse; R F DiGiacomo; G L Van Hoosier; J Condon
Journal:  Lab Anim Sci       Date:  1981-02

6.  Antibiotic susceptibilities of human isolates of Pasteurella multocida.

Authors:  D L Stevens; J W Higbee; T R Oberhofer; E D Everett
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

Review 7.  Pasteurella multocida infections. Report of 34 cases and review of the literature.

Authors:  D J Weber; J S Wolfson; M N Swartz; D C Hooper
Journal:  Medicine (Baltimore)       Date:  1984-05       Impact factor: 1.889

8.  [Characterization of Pasteurella species isolated from man].

Authors:  J L Avril; P Y Donnio
Journal:  Pathol Biol (Paris)       Date:  1987-02

Review 9.  Pasteurella multocida infections. II. Pasteurella multocida infection in man unrelated to animal bite.

Authors:  W T Hubbert; M N Rosen
Journal:  Am J Public Health Nations Health       Date:  1970-06
  9 in total
  6 in total

Review 1.  Oral and intestinal bacterial exotoxins: Potential linked to carcinogenesis.

Authors:  Matthew Silbergleit; Adrian A Vasquez; Carol J Miller; Jun Sun; Ikuko Kato
Journal:  Prog Mol Biol Transl Sci       Date:  2020-04-09       Impact factor: 3.622

2.  Pasteurella stomatis infection following a dog bite.

Authors:  P Pouëdras; P Y Donnio; Y Le Tulzo; J L Avril
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-01       Impact factor: 3.267

Review 3.  Pasteurella multocida: from zoonosis to cellular microbiology.

Authors:  Brenda A Wilson; Mengfei Ho
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

4.  Spontaneous bacterial peritonitis by Pasteurella multocida under treatment with rifaximin.

Authors:  P Lutz; M Parcina; I Bekeredjian-Ding; A Hoerauf; C P Strassburg; U Spengler
Journal:  Infection       Date:  2013-03-25       Impact factor: 3.553

5.  Serological response to Pasteurella multocida NanH sialidase in persistently colonized rabbits.

Authors:  Susan Sanchez; Shaikh Mizan; Charlotte Quist; Patricia Schroder; Michelle Juneau; Donald Dawe; Branson Ritchie; Margie D Lee
Journal:  Clin Diagn Lab Immunol       Date:  2004-09

6.  Impact of rifaximin on the frequency and characteristics of spontaneous bacterial peritonitis in patients with liver cirrhosis and ascites.

Authors:  Philipp Lutz; Marijo Parcina; Isabelle Bekeredjian-Ding; Hans Dieter Nischalke; Jacob Nattermann; Tilman Sauerbruch; Achim Hoerauf; Christian P Strassburg; Ulrich Spengler
Journal:  PLoS One       Date:  2014-04-08       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.